Dr Boreham’s Crucible: Did this ASX biotech hit unicorn status without significant hurdles? Of Coris not
Nanosonics (ASX:NAN) chief Michael Kavanagh says he’s “very proud” of the device maker’s ability to win US Food and Drug ...